e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Victoria Ptasinski, Sweden
Source:
ERS Lung Science Conference 2021
Number:
75
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Victoria Ptasinski, Sweden. PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids. ERS Lung Science Conference 2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension
Related content which might interest you:
LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Engineering distal pulmonary epithelium from induced pluripotent stem cell (iPSC)-derived alveolar cells
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021
Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018
PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021
Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
Source: Eur Respir Monogr 2021; 91: 290-305
Year: 2021
Mechanical programming of mesenchymal stromal cells to treat lung fibrosis
Source: ERS Lung Science Conference 2018
Year: 2018
Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Pulmonary interstitial glycogenosis cells express mesenchymal stem cell markers
Source: Eur Respir J, 56 (4) 2000853; 10.1183/13993003.00853-2020
Year: 2020
Pulmonary fibrosis modulation by mesenchymal stem cells and conditioned medium
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Lineage differentiation of pulmonary alveolar fibroblasts
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Derivation of epithelial-only airway organoids from human pluripotent stem cells
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept